Browse by Journals

HEALD, A., REYNOLDS, Gavin, NASH, I., BOYLE, O., DALY, C., LONGSON, D., SHI, L., STEDMAN, M. and SYED, A. (2026). Obesity and schizophrenia: results of a feasibility study with semaglutide to assist weight loss [abstract only]. Neuroscience Applied, 5 (Supp 1): 105758. [Article]

LOUREIRO, C., CORSI-ZUELLI, F., FACHIM, H., SHUHAMA, R., MENEZES, P.R., DALTON, Caroline, LOUZADA-JUNIOR, P., BELANGERO, S.I., COELI-LACCHINI, F., REYNOLDS, G.P., LACCHINI, R. and DEL-BEN, C.M. (2022). Gene and environmental risk factors: interplay between CNR1 genetic variants cannabis use, childhood trauma and psychosis [abstract only]. Neuroscience Applied, 1 (Supp 2): 100565. [Article]

LOUREIRO, Camila, SHUHAMA, R., CORSI-ZUELLI, F., FACHIM, H., DALTON, Caroline, MENEZES, P. Rossi, LOUZADA-JUNIOR, P., DEL-BEN, C. and REYNOLDS, Gavin (2023). Body mass index and metabolic changes following antipsychotic drug treatment of first-episode psychosis: influences of childhood trauma and tobacco smoking [abstract only]. Neuroscience Applied, 2: 103026. [Article]

MALAVIYA, A., MCGOWAN, O.O. and REYNOLDS, Gavin (2026). Cardiovascular disease and mortality in people with psychosis – a health record study [abstract only]. Neuroscience Applied, 5 (Supp 1): 106607. [Article]

WILKINS, L., WARNER-LEVY, J., MEEHAN, C., BELSTON, L., LOUREIRO, C., DALTON, Caroline and HEALD, A. (2024). Associations between antipsychotic induced weight gain and antipsychotic prescriptions: an observational retrospective cohort study [abstract]. Neuroscience Applied, 3 (Supp 2), p. 105229. [Article]